Autopsy report · NCT02483533
Extension Study to Evaluate the Post-Treatment Safety and Duration of Clinical Effect of LIPO-202
Cause of deathNo reason given
Life of this trial
- Ran for about 8 months before it stopped.
- 100 participants enrolled.
- Results were posted on the registry 3 years 9 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Evofem Inc.
- Sponsor type
- Industry
- Conditions
- Central Abdominal Bulging
- Interventions
- LIPO-202; Placebo
- Participants
- 100
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.